Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Tecnoglass Holdings
TGLS
$1.8B
| $21.5M | 0.01% |
416,588
-306,372
| -42% | -$13.6M |
|
1302
CALL
Prudential Financial
PRU
$42.3B
| $21.5M | 0.01% |
243,900
-82,900
| -25% | -$6.94M |
|
1303
Ambev
ABEV
$45B
| $21.5M | 0.01% |
6,763,443
-7,833,705
| -54% | -$23M |
|
1304
CALL
Humana
HUM
$46.4B
| $21.5M | 0.01% |
48,100
-34,500
| -42% | -$17.4M |
|
1305
Sunrun
RUN
$2.15B
| $21.5M | 0.01% |
1,204,080
+101,532
| +9% | +$1.89M |
|
1306
CALL
First Solar
FSLR
$22.4B
| $21.5M | 0.01% |
113,000
+74,200
| +191% | +$14.7M |
|
|
MRSH
1307
CALL
Marsh
MRSH
$92.9B
| $21.4M | 0.01% |
114,000
+5,400
| +5% | +$958K |
|
1308
CALL
Progressive
PGR
$130B
| $21.4M | 0.01% |
161,800
+81,800
| +102% | +$11M |
|
1309
CALL
TC Energy
TRP
$64.7B
| $21.4M | 0.01% |
400,000
+148,800
| +59% | +$6.07M |
|
1310
PUT
Yum! Brands
YUM
$42.9B
| $21.3M | 0.01% |
153,400
-37,800
| -20% | -$5.12M |
|
1311
OmniAb
OABI
$685M
| $21.2M | 0.01% |
4,336,079
-1,133,499
| -21% | -$4.6M |
|
|
KDNY
1312
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $21.2M | 0.01% |
552,166
+303,712
| +122% | +$7.8M |
|
1313
CALL
Workday
WDAY
$49.2B
| $21.2M | 0.01% |
+93,900
| New | +$18.8M |
|
1314
CALL
United Microelectronic
UMC
$47.8B
| $21.2M | 0.01% |
2,682,500
+30,000
| +1% | +$247K |
|
1315
Highwoods Properties
HIW
$3.5B
| $21.2M | 0.01% |
885,167
+690,774
| +355% | +$15.3M |
|
1316
Leggett & Platt
LEG
$1.28B
| $21.1M | 0.01% |
713,405
+518,633
| +266% | +$16.3M |
|
1317
AbCellera Biologics
ABCL
$3.44B
| $21.1M | 0.01% |
3,267,618
+2,060,920
| +171% | +$14.1M |
|
1318
PUT
Aflac
AFL
$59.3B
| $21.1M | 0.01% |
302,400
-68,700
| -19% | -$4.6M |
|
1319
PUT
LyondellBasell Industries
LYB
$21.1B
| $21.1M | 0.01% |
229,800
-321,400
| -58% | -$29.4M |
|
1320
Myriad Genetics
MYGN
$292M
| $21.1M | 0.01% |
908,448
-476,943
| -34% | -$10.4M |
|
1321
Hormel Foods
HRL
$13.3B
| $21M | 0.01% |
522,899
+296,513
| +131% | +$11.9M |
|
1322
CALL
iShares MSCI Brazil ETF
EWZ
$8.07B
| $21M | 0.01% |
647,100
-1,422,800
| -69% | -$42.3M |
|
1323
PUT
Moderna
MRNA
$55.4B
| $21M | 0.01% |
172,500
+16,000
| +10% | +$2.13M |
|
1324
Baytex Energy
BTE
$3.3B
| $20.9M | 0.01% |
6,423,904
+4,964,216
| +340% | +$17.4M |
|
1325
Hanover Insurance
THG
$7.92B
| $20.9M | 0.01% |
185,277
+29,930
| +19% | +$3.55M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.